# OnCo record cellogen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/cellogen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "cellogen" ;
  schema:name "Cellogen Therapeutics"@en ;
  schema:description "A Delhi start-up developing bispecific CD19 and CD20 CAR-T cells and gene therapies for thalassaemia, aiming to cut treatment costs by up to 90%; still before its first trial."@en ;
  schema:url <https://onco.cc/companies/cellogen/>, <https://www.cellogentherapeutics.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.cellogentherapeutics.com> ;
  onco:status "preclinical" ;
  schema:addressCountry "IN" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/cd20/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-manufacturing-cell-therapy/> .